Swanbridge CapitalSwanbridge Capital is an early-stage venture capital fund that is focused on (pre-)seed investments in the life sciences industry. The fund invests in the development of novel therapeutics, diagnostics and medical devices. Swanbridge Capital was founded in 2016 and is based in Rotterdam, the Netherlands.
For more information: www.swanbridgecapital.nl
Van Herk VenturesVan Herk Ventures is part of the Rotterdam-based Van Herk Groep and holds a portfolio of investments in real estate, energy and life sciences. The Van Herk Groep invests in the life sciences sector through direct investments in private and listed companies and in venture capital funds. Major investments include Galapagos, Zealand Pharma, BioInvent, DCprime, Ablynx (sold to Sanofi), and Crucell (sold to J&J).
For more information: www.vanherkgroep.nl/beleggingen.